Text of MO SJR 27 (2025)
Establishes provisions relating to reproductive health care
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
2,825 characters
FIRST REGULAR SESSION
SENATE JOINT RESOLUTION NO. 27
103RD GENERAL ASSEMBLY
INTRODUCED BY SENATOR CARTER.
1007S.02I
KRISTINA MARTIN, Secretary
JOINT RESOLUTION
Submitting to the qualified voters of Missouri, an amendment to article I of the Constitution of
Missouri, by adding thereto one new section relating to reproductive health care.
Be it resolved by the Senate, the House of Representatives concurring therein:
That at the next general election to be held in the
1
state of Missouri, on Tuesday next following the first Monday
2
in November, 2026, or at a special election to be called by
3
the governor for that purpose, there is hereby submitted to
4
the qualified voters of this state, for adoption or
5
rejection, the following amendment to article I of the
6
Constitution of the state of Missouri:
7
Section A. Article I, Constitution of Missouri, is amended
1
by adding thereto one new section, to be known as section 36(a),
2
to read as follows:
3
Section 36(a). 1. Notwithstanding any provision of
1
section 36 of article I of this Constitution to the
2
contrary, the right to reproductive freedom shall not be
3
construed to include the performance of gender transition
4
surgeries on children under eighteen years of age or the
5
prescription or administration of cross-sex hormones or
6
puberty-blocking drugs for the purpose of gender transition
7
to children under eighteen years of age. The provisions of
8
this section shall not apply to the use of such surgeries,
9
drugs, or hormones to treat children born with a medically
10
verifiable disorder of sex development or to treat any
11
SJR 27
2
infection, injury, disease, or disorder unrelated to the
12
purpose of a gender transition.
13
2. As used in this section, the following terms shall
14
mean:
15
(1) "Cross-sex hormones", testosterone, estrogen, or
16
other androgens given to an individual in amounts that are
17
greater or more potent than would normally occur naturally
18
in a healthy individual of the same age and sex;
19
(2) "Gender transition surgery", a surgical procedure
20
performed for the purpose of assisting an individual to
21
identify with and live as a gender different from his or her
22
biological sex;
23
(3) "Puberty-blocking drugs", gonadotropin-releasing
24
hormone analogues or other synthetic drugs used to stop
25
luteinizing hormone secretion and follicle stimulating
26
hormone secretion, synthetic antiandrogen drugs to block the
27
androgen receptor, or any other drug used to delay or
28
suppress pubertal development in children for the purpose of
29
assisting an individual with a gender transition.
30